Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Stephen J. Thomas, Edson D. Moreira Jr., Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cristiano Zerbini, Ruth Bailey, Kena A. Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V. Kalina, David Cooper, Robert W. Frenck Jr., Laura L. Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B. Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen, C4591001 Clinical Trial Group
doi: https://doi.org/10.1101/2021.07.28.21261159

Article Information

doi 
https://doi.org/10.1101/2021.07.28.21261159
History 
  • July 28, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Stephen J. Thomas, M.D.1,
  2. Edson D. Moreira Jr., M.D.2,
  3. Nicholas Kitchin, M.D.3a,
  4. Judith Absalon, M.D.3b,*,
  5. Alejandra Gurtman, M.D.3b,
  6. Stephen Lockhart, D.M.3a,
  7. John L. Perez, M.D.3c,
  8. Gonzalo Pérez Marc, M.D.4,
  9. Fernando P. Polack, M.D.5,
  10. Cristiano Zerbini, M.D.6,
  11. Ruth Bailey, B.Sc.3a,
  12. Kena A. Swanson, Ph.D.3b,
  13. Xia Xu, Ph.D.3c,
  14. Satrajit Roychoudhury, Ph.D.7,
  15. Kenneth Koury, Ph.D.3b,
  16. Salim Bouguermouh, M.D., Ph.D.3b,
  17. Warren V. Kalina, Ph.D.3b,
  18. David Cooper, Ph.D.3b,
  19. Robert W. Frenck Jr., M.D.8,
  20. Laura L. Hammitt, M.D.9,
  21. Özlem Türeci, M.D.10,
  22. Haylene Nell, M.D.11,
  23. Axel Schaefer, M.D.12,
  24. Serhat Ünal, M.D.13,
  25. Qi Yang, Ph.D.3b,
  26. Paul Liberator, Ph.D.3b,
  27. Dina B. Tresnan, D.V.M., Ph.D.14a,
  28. Susan Mather, M.D.14b,
  29. Philip R. Dormitzer, M.D., Ph.D.3b,
  30. Uğur Şahin, M.D.10,
  31. William C. Gruber, M.D.3b,
  32. Kathrin U. Jansen, Ph.D.3b,
  33. C4591001 Clinical Trial Group
  1. 1State University of New York, Upstate Medical University, Syracuse, NY
  2. 2Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia, Brazil
  3. 3aVaccine Research and Development, Pfizer Inc, Hurley, UK
  4. 3bVaccine Research and Development, Pfizer Inc, Pearl River, NY
  5. 3cVaccine Research and Development, Pfizer Inc, Collegeville, PA
  6. 4iTrials-Hospital Militar Central, Buenos Aires, Argentina
  7. 5Fundacion INFANT, Buenos Aires, Argentina
  8. 6Centro Paulista de Investigação Clinica, São Paulo, Brazil
  9. 7Global Product Development, Pfizer Inc, Peapack, NJ
  10. 8Cincinnati Children’s Hospital, Cincinnati, OH
  11. 9Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  12. 10BioNTech, Mainz, Germany
  13. 11Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa
  14. 12Medizentrum Essen Borbeck, Essen, Germany
  15. 13Hacettepe University, Ankara, Turkey
  16. 14aWorldwide Safety, Safety Surveillance and Risk Management, Pfizer, Inc, Groton, CT
  17. 14bWorldwide Safety, Safety Surveillance and Risk Management, Pfizer, Inc, Collegeville, PA
  1. ↵*Corresponding Author: Judith Absalon, M.D., M.P.H., F.I.D.S.A., Pfizer Inc, 401 North Middletown Road, Pearl River, NY 10965, Judith.Absalon{at}pfizer.com
Back to top
Posted July 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
Stephen J. Thomas, Edson D. Moreira Jr., Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Fernando P. Polack, Cristiano Zerbini, Ruth Bailey, Kena A. Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V. Kalina, David Cooper, Robert W. Frenck Jr., Laura L. Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B. Tresnan, Susan Mather, Philip R. Dormitzer, Uğur Şahin, William C. Gruber, Kathrin U. Jansen, C4591001 Clinical Trial Group
medRxiv 2021.07.28.21261159; doi: https://doi.org/10.1101/2021.07.28.21261159
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area